• Mon. Oct 26th, 2026

modified

  • Home
  • Genetically Modified Donor Stem Cells Show Promise in Overcoming Major Hurdle for Blood Cancer Immunotherapies

Genetically Modified Donor Stem Cells Show Promise in Overcoming Major Hurdle for Blood Cancer Immunotherapies

For individuals battling some of the most aggressive forms of blood cancer, a stem cell transplant often represents the single remaining treatment option with the potential to achieve a lasting…